Epistaxis without MCC: Inpatient Reimbursement Overview
DRG 151 addresses inpatient admissions for epistaxis without Major Complication or Comorbidity, focusing on cases where nasal bleeding is the principal diagnosis. Understanding this Diagnosis-Related Group is important for inpatient reimbursement because it determines grouping and payment under the Medicare prospective payment framework.
Customize your policy alerts
Sign up for drg 151 policy alerts
Get alerted when payer policies referencing 151 are released or updated.
Monitor payer policy activity
DRG 151 Overview
DRG 151 covers inpatient admissions for epistaxis without Major Complication or Comorbidity. This Diagnosis-Related Group applies to cases where nasal bleeding is the principal diagnosis and no major complications or comorbid conditions are coded. It matters for Medicare payment because it groups clinically similar hospital stays to determine a standardized prospective payment amount for inpatient services. Accurate coding of associated conditions influences hospital reimbursement under the Medicare inpatient prospective payment system.